641
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma

, , &
Pages 201-202 | Received 21 Nov 2016, Accepted 08 Feb 2017, Published online: 24 Mar 2017

References

  • Kim H. Composite lymphoma and related disorders. Am J Clin Pathol 1993; 99(4):445-51; PMID:8475911; http://dx.doi.org/10.1093/ajcp/99.4.445
  • Micallef IN, Kirk A, Norton A, Foran JM, Rohatiner AZ, Lister TA. Peripheral t-cell lymphoma following rituximab therapy for b-cell lymphoma. Blood 1999; 93(7):2427-8; PMID:10215354
  • Kilner MF, Merante S, Svec A. The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers? BMJ Case Rep 2013; 2013:pii: bcr2013200079; PMID:24343800; http://dx.doi.org/10.1136/bcr-2013-200079
  • Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, et al. Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. J Clin Oncol 2011; 29(7):814-24; PMID:21189387; http://dx.doi.org/10.1200/JCO.2010.28.9777

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.